Literature DB >> 31387188

Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.

Yuhang Xiao1, Min Su2, Wei Ou3, Hui Wang4, Bo Tian5, Junliang Ma5, Jinming Tang5, Jie Wu5, Zhining Wu5, Wenxiang Wang6, Yong Zhou7.   

Abstract

Esophageal cancer (EC) is a serious digestive malignancy and is a leading cause of cancer-related mortality. Apart from genetic mutations, many epigenetic alterations including DNA methylation and histone modifications associated with chromatin remodeling have been identified in the regulation of gene expression in EC. Recently, noncoding RNAs, and mainly lncRNAs and miRNAs, have been revealed to be involved in the epigenetic regulation of EC. In this review, we focus on describing new insights on epigenetic processes associated with noncoding RNAs, which have been characterized to be responsible for the development and progression of EC.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  DNA methylation; Epigenetic alteration; Esophageal cancer; Histone modification; Noncoding RNA; lncRNA; miRNA

Mesh:

Substances:

Year:  2019        PMID: 31387188     DOI: 10.1016/j.biopha.2019.109192

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  Circ_0006948 Contributes to Cell Growth, Migration, Invasion and Epithelial-Mesenchymal Transition in Esophageal Carcinoma.

Authors:  Meng Yue; Yanxia Liu; Taiyang Zuo; Yakun Jiang; Jianmei Pan; Shuhong Zhang; Xingjie Shen
Journal:  Dig Dis Sci       Date:  2021-02-25       Impact factor: 3.199

Review 2.  Long non-coding RNAs regulate drug resistance in cancer.

Authors:  Kaisheng Liu; Lin Gao; Xiaoshi Ma; Juan-Juan Huang; Juan Chen; Leli Zeng; Charles R Ashby; Chang Zou; Zhe-Sheng Chen
Journal:  Mol Cancer       Date:  2020-03-12       Impact factor: 27.401

3.  Identification of Potential Long Non-coding RNA Expression Quantitative Trait Methylations in Lung Adenocarcinoma and Lung Squamous Carcinoma.

Authors:  Xiaohong Wu; Yue Gao; Jianlong Bu; Lin Deng; Pinyi Zhang; Meng Chi; Lihua Jiang; Xiaoding Shi; Shangwei Ning; Guonian Wang
Journal:  Front Genet       Date:  2020-12-09       Impact factor: 4.599

Review 4.  Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer.

Authors:  Deniz Mortazavi; Behnoush Sohrabi; Meysam Mosallaei; Ziba Nariman-Saleh-Fam; Milad Bastami; Yaser Mansoori; Abdolreza Daraei; Sepideh Zununi Vahed; Shadan Navid; Zahra Saadatian; Tannaz Jamialahmadi; Yong Teng; Amirhossein Sahebkar
Journal:  J Oncol       Date:  2022-01-11       Impact factor: 4.375

Review 5.  An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential.

Authors:  Małgorzata Guz; Witold Jeleniewicz; Marek Cybulski
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

6.  LINC00261 Suppresses Cisplatin Resistance of Esophageal Squamous Cell Carcinoma Through miR-545-3p/MT1M Axis.

Authors:  Lijun Wang; Xiaojun Wang; Pengwei Yan; Yatian Liu; Xuesong Jiang
Journal:  Front Cell Dev Biol       Date:  2021-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.